Emergency Medical Technician (EMT) Intermediate Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the EMT Intermediate Exam. Access detailed flashcards and multiple-choice questions that come with hints and explanations. Prepare comprehensively for your EMT certification!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

To minimize brain-cell damage in an ischemic stroke patient, fibrinolytic therapy should be administered within:

1 hour after symptom onset
3 hours after symptom onset
6 hours after symptom onset
12 hours after symptom onset

The correct answer is: 3 hours after symptom onset

Fibrinolytic therapy, often involving agents like tissue plasminogen activator (tPA), is critically time-sensitive in the context of an ischemic stroke. The goal of this therapy is to dissolve the blood clot obstructing blood flow to the brain, thereby restoring circulation and minimizing brain cell damage. Research supports that the optimal window for administering fibrinolytic therapy is within three hours of symptom onset. Administering treatment within this timeframe significantly improves the chances of recovery and can lead to better long-term outcomes. Beyond this three-hour window, although up to 4.5 hours may still be feasible in some cases with specific criteria, the likelihood of complications and the potential for lesser benefits increase substantially as time progresses. The other options listed fall outside this critical three-hour guideline, indicating longer time frames that are less effective for intervention. Therefore, recognizing that administering fibrinolytic therapy within three hours of symptom onset is essential for minimizing brain damage underscores the importance of time in the treatment of ischemic strokes.